These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15167724)

  • 1. Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.
    Kwiat DM; Bersani TA; Bersani A
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):186-9. PubMed ID: 15167724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
    Allen SB; Goldenberg NA
    Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial.
    Alam M; Dover JS; Arndt KA
    Arch Dermatol; 2002 Apr; 138(4):510-4. PubMed ID: 11939813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial.
    van Laborde S; Dover JS; Moore M; Stewart B; Arndt KA; Alam M
    J Am Acad Dermatol; 2003 Jun; 48(6):875-7. PubMed ID: 12789177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
    Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
    Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
    Gassner HG; Sherris DA
    Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriostatic preserved saline for pain-free periocular injections: review.
    Hunt SV; Malhotra R
    Eye (Lond); 2022 Aug; 36(8):1546-1552. PubMed ID: 35017698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
    Mezaki T; Kaji R; Brin MF; Hirota-Katayama M; Kubori T; Shimizu T; Kimura J
    Mov Disord; 1999 Nov; 14(6):1017-20. PubMed ID: 10584680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
    Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
    J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cooling before periocular botulinum toxin A injection.
    Linder JS; Edmonson BC; Laquis SJ; Drewry RD; Fleming JC
    Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):441-2. PubMed ID: 12439058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botox: shaken, not stirred.
    Kazim NA; Black EH
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):10-2. PubMed ID: 18209633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.